144 related articles for article (PubMed ID: 22686853)
41. Use of human monoclonal antibodies to treat Chikungunya virus infection.
Fric J; Bertin-Maghit S; Wang CI; Nardin A; Warter L
J Infect Dis; 2013 Jan; 207(2):319-22. PubMed ID: 23125446
[TBL] [Abstract][Full Text] [Related]
42. Molecular investigations of chikungunya virus during outbreaks in Orissa, Eastern India in 2010.
Das B; Sahu A; Das M; Patra A; Dwibedi B; Kar SK; Hazra RK
Infect Genet Evol; 2012 Jul; 12(5):1094-101. PubMed ID: 22484761
[TBL] [Abstract][Full Text] [Related]
43. [An imported Chikungunya fever case from New Delhi, India to Ankara, Turkey: the first imported case of Turkey and review of the literature].
Yağcı Çağlayık D; Uyar Y; Korukluoğlu G; Ertek M; Unal S
Mikrobiyol Bul; 2012 Jan; 46(1):122-8. PubMed ID: 22399181
[TBL] [Abstract][Full Text] [Related]
44. Acute Chikungunya and persistent musculoskeletal pain following the 2006 Indian epidemic: a 2-year prospective rural community study.
Chopra A; Anuradha V; Ghorpade R; Saluja M
Epidemiol Infect; 2012 May; 140(5):842-50. PubMed ID: 21767452
[TBL] [Abstract][Full Text] [Related]
45. Factors associated with persistence of arthralgia among Chikungunya virus-infected travellers: report of 42 French cases.
Larrieu S; Pouderoux N; Pistone T; Filleul L; Receveur MC; Sissoko D; Ezzedine K; Malvy D
J Clin Virol; 2010 Jan; 47(1):85-8. PubMed ID: 20004145
[TBL] [Abstract][Full Text] [Related]
46. Seroprevalence of Chikungunya virus infection on Grande Comore Island, union of the Comoros, 2005.
Sergon K; Yahaya AA; Brown J; Bedja SA; Mlindasse M; Agata N; Allaranger Y; Ball MD; Powers AM; Ofula V; Onyango C; Konongoi LS; Sang R; Njenga MK; Breiman RF
Am J Trop Med Hyg; 2007 Jun; 76(6):1189-93. PubMed ID: 17556634
[TBL] [Abstract][Full Text] [Related]
47. Persistent arthralgia associated with chikungunya virus: a study of 88 adult patients on reunion island.
Borgherini G; Poubeau P; Jossaume A; Gouix A; Cotte L; Michault A; Arvin-Berod C; Paganin F
Clin Infect Dis; 2008 Aug; 47(4):469-75. PubMed ID: 18611153
[TBL] [Abstract][Full Text] [Related]
48. Deciphering the differential response of two human fibroblast cell lines following Chikungunya virus infection.
Thon-Hon VG; Denizot M; Li-Pat-Yuen G; Giry C; Jaffar-Bandjee MC; Gasque P
Virol J; 2012 Sep; 9():213. PubMed ID: 22992396
[TBL] [Abstract][Full Text] [Related]
49. Update: chikungunya fever diagnosed among international travelers--United States, 2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Mar; 56(12):276-7. PubMed ID: 17392679
[TBL] [Abstract][Full Text] [Related]
50. A Systematic Meta-analysis of Immune Signatures in Patients With Acute Chikungunya Virus Infection.
Teng TS; Kam YW; Lee B; Hapuarachchi HC; Wimal A; Ng LC; Ng LF
J Infect Dis; 2015 Jun; 211(12):1925-35. PubMed ID: 25635123
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of the first commercial chikungunya virus indirect immunofluorescence test.
Litzba N; Schuffenecker I; Zeller H; Drosten C; Emmerich P; Charrel R; Kreher P; Niedrig M
J Virol Methods; 2008 Apr; 149(1):175-9. PubMed ID: 18294706
[TBL] [Abstract][Full Text] [Related]
52. A polarized cell model for Chikungunya virus infection: entry and egress of virus occurs at the apical domain of polarized cells.
Lim PJ; Chu JJ
PLoS Negl Trop Dis; 2014 Feb; 8(2):e2661. PubMed ID: 24587455
[TBL] [Abstract][Full Text] [Related]
53. Chikungunya virus-associated death in Malaysia.
Sam IC; Kamarulzaman A; Ong GS; Veriah RS; Ponnampalavanar S; Chan YF; AbuBakar S
Trop Biomed; 2010 Aug; 27(2):343-7. PubMed ID: 20962735
[TBL] [Abstract][Full Text] [Related]
54. Differential proteome analysis of Chikungunya virus-infected new-born mice tissues reveal implication of stress, inflammatory and apoptotic pathways in disease pathogenesis.
Dhanwani R; Khan M; Alam SI; Rao PV; Parida M
Proteomics; 2011 May; 11(10):1936-51. PubMed ID: 21472854
[TBL] [Abstract][Full Text] [Related]
55. The biology of chikungunya: a brief review of what we still do not know.
Pardigon N
Pathol Biol (Paris); 2009 Mar; 57(2):127-32. PubMed ID: 18456435
[TBL] [Abstract][Full Text] [Related]
56. An animal model for studying the pathogenesis of chikungunya virus infection.
Ziegler SA; Lu L; da Rosa AP; Xiao SY; Tesh RB
Am J Trop Med Hyg; 2008 Jul; 79(1):133-9. PubMed ID: 18606777
[TBL] [Abstract][Full Text] [Related]
57. Expression and evaluation of Chikungunya virus E1 and E2 envelope proteins for serodiagnosis of Chikungunya virus infection.
Cho B; Jeon BY; Kim J; Noh J; Kim J; Park M; Park S
Yonsei Med J; 2008 Oct; 49(5):828-35. PubMed ID: 18972604
[TBL] [Abstract][Full Text] [Related]
58. Focus on Chikungunya pathophysiology in human and animal models.
Couderc T; Lecuit M
Microbes Infect; 2009 Dec; 11(14-15):1197-205. PubMed ID: 19737626
[TBL] [Abstract][Full Text] [Related]
59. Mapping interactions of Chikungunya virus nonstructural proteins.
Sreejith R; Rana J; Dudha N; Kumar K; Gabrani R; Sharma SK; Gupta A; Vrati S; Chaudhary VK; Gupta S
Virus Res; 2012 Oct; 169(1):231-6. PubMed ID: 22951312
[TBL] [Abstract][Full Text] [Related]
60. Single-cell analysis of arthritogenic alphavirus-infected human synovial fibroblasts links low abundance of viral RNA to induction of innate immunity and arthralgia-associated gene expression.
Pott F; Postmus D; Brown RJP; Wyler E; Neumann E; Landthaler M; Goffinet C
Emerg Microbes Infect; 2021 Dec; 10(1):2151-2168. PubMed ID: 34723780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
